Letitia Pienaar | Pharmaceutical Policy and Regulation | Best Researcher Award

Dr. Letitia Pienaar | Pharmaceutical Policy and Regulation | Best Researcher Award

Associate Prof at University of South Africa | South Africa

Dr. Letitia Pienaar is a distinguished academic, attorney, and researcher specializing in mental health law, medical jurisprudence, and criminal justice. Currently an Associate Professor at the University of South Africa, she brings decades of expertise in higher education, legal practice, and multidisciplinary research. Her work bridges law, health, and ethics, with a strong focus on disability rights, forensic mental health, and inclusive education. Having served on numerous advisory boards, professional committees, and international collaborations, Dr. Pienaar combines practical legal experience with academic leadership, contributing significantly to policy, legal reform, and the advancement of justice in healthcare and mental health systems.

Publication Profile 

Google Scholar

Education 

Dr. Letitia Pienaar holds an LL.D in Mental Health Law and the Criminal Justice System from the University of South Africa, along with an LL.M specializing in Medical Jurisprudence, HIV/AIDS Law, and Delictual Damages. She completed advanced certificates in Medicine and Law, Child Law, National Credit Act implications, and Disability Rights in Africa from the Universities of Pretoria and South Africa. Her foundational degree, LL.B, was obtained from Rand Afrikaans University. Additionally, she is a certified assessor in higher education and has undertaken training in inclusive education, healthcare rights, and bioethics, complementing her extensive legal and academic qualifications.

Experience 

Dr. Letitia Pienaar is an Associate Professor at the University of South Africa, lecturing in Medical Law, Forensic Medicine, and Criminal Law while supervising postgraduate research. She previously served as Senior Legal Specialist at First National Bank, focusing on legal compliance and regulatory matters. Her legal career began at Hofmeyr Herbstein & Gihwala Inc, specializing in litigation for corporate clients. Beyond academia, she has contributed to research ethics committees, disability rights advocacy, and policy development initiatives. Her expertise spans higher education, legal drafting, research ethics, and medical law, with substantial experience managing academic programs, research collaborations, and interdisciplinary legal-healthcare projects.

Awards and Honors 

Dr. Letitia Pienaar has been recognized for her academic excellence, professional contributions, and leadership in law and health ethics. She has served on advisory boards such as the University of Washington Delphi Study on mental health and AIDS in African prisons and as a member of the International Association of Forensic Mental Health’s Equality, Diversity, and Inclusion Committee. Her role in inclusive education and healthcare working streams for the D20 underscores her international standing. She has also contributed to UNESCO’s Bioethics initiatives and African mental health forums, reflecting her commitment to advancing human rights, legal reform, and healthcare justice.

Research Focus 

Dr. Letitia Pienaar research focuses on the intersection of law, health, and human rights, with particular emphasis on mental health law, forensic medicine, and disability rights. She explores ethical, legal, and policy dimensions in healthcare, criminal justice, and inclusive education. Her work addresses HIV/AIDS law, child protection, forensic mental health, and bioethics, integrating legal research with public health imperatives. Through advisory roles, academic publications, and postgraduate supervision, she advances interdisciplinary scholarship that informs legal reforms, healthcare regulations, and human rights protections. Her research contributes to building inclusive legal-health frameworks and shaping discourse around mental health justice and medical law ethics.

Publication Top Notes

Investigating the reasons behind the increase in medical negligence claims

Considering Mental Health Courts for South Africa: Lessons from Canada and the United States of America

Deciphering the Composition of Section 79-Assessment Panels in the Criminal Procedure Amendment Act 4 of 2017

Determination of criminal capacity for child offenders-interfacing the procedural requirements of the Child Justice and Criminal Procedure Act

Plausible subjective experience versus fallible corroborative evidence: The formulation of insanity in Nigerian criminal courts

The unfit accused in the South African criminal justice system: From automatic detention to unconditional release

The DSM-5 and the role of personality disorders under the criminal law

Access to the medical records of a child: legislative review required

Compulsory HIV testing of child sex offenders in the South African criminal justice system

Facilitating a framework for managing rare diseases in South Africa: Comparative insights from the UK and Italy

Priorities for addressing mental health conditions and substance use disorders in prisons in sub-Saharan Africa: expert consensus from a Delphi panel

The Evolution of Mental Health Legislation in South Africa: Towards a Rights-Based Approach

Low-threshold fitness test in South Africa and the USA : consequences for the fit but mentally ill accused

Mentally ill accused in South African criminal procedure Evaluating the mental health court model as therapeutic response:

Conclusion

Dr. Letitia Pienaar demonstrates outstanding academic, research, and professional achievements that align strongly with the criteria for the Best Researcher Award. Her interdisciplinary expertise in law, mental health, and human rights, combined with significant teaching, publication, and professional engagement experience, make her an ideal candidate. With further expansion into global research collaborations and high-impact international publications, she has the potential to become a leading voice in her field worldwide.

Anchalee Avihingsanon | Pharmaceutical Policy and Regulation | Best Researcher Award

Anchalee Avihingsanon | Pharmaceutical Policy and Regulation | Best Researcher Award

Dr. Anchalee Avihingsanon, HIV-NAT, Thai Red Cross AIDS and Infectious Diseases Research Collaboration, Thailand

Dr. Anchalee Avihingsanon, MD, PhD 🩺🔬 is a distinguished infectious disease specialist with over 20 years of expertise in HIV/AIDS, tuberculosis, and viral hepatitis research. She leads the HIV-NAT clinical research program at the Thai Red Cross AIDS and Infectious Disease Research Centre in Bangkok 🇹🇭 and serves as Clinical Research Site Leader for ACTG. Dr. Avihingsanon actively shapes national health policies in Thailand and contributes to WHO guideline development 🌏. Her international research spans clinical trials addressing HIV, TB, and emerging infections. She has earned numerous awards for her impactful work in resource-limited settings.

Publication Profile

Orcid

Education

Dr. Anchalee Avihingsanon completed her medical degree (MD) at Khon Kaen University, Thailand, from 1986 to 1992. She then specialized in Internal Medicine at Chulalongkorn University, Bangkok, during 1994-1996, followed by a focus on Infectious Disease from 1998 to 1999 at the same institution. Dr. Avihingsanon advanced her expertise as a research fellow in Infectious Diseases at Beth Israel Deaconess Medical Center in Boston, USA, from 2000 to 2002. She earned her PhD in HIV and Coinfection at Amsterdam University, The Netherlands, between 2011 and 2013.

Experience

Dr. Anchalee Avihingsanon has been actively involved in numerous professional roles since 1999. She currently serves as the ACTG Regional Representative for Asia and is a key member of several WHO advisory groups on HIV, viral hepatitis, and STIs. She is also an infectious disease expert on Bangkok’s Essential Medicine Committee and contributes to national efforts on AIDS, TB, and hepatitis. Dr. Avihingsanon participates in multiple research and guideline committees, including the Thai Ministry of Public Health and international scientific groups. She holds memberships in prestigious organizations like the International AIDS Society and the Royal College of Physicians.

Awards

Dr. Anchalee Avihingsanon has received numerous honors throughout her career. In 2016, she successfully passed the US-FDA inspection for key studies. She was awarded the Australia-APEC Women in Research Fellowship in 2015 and received the prestigious NUFFIC PhD grant from the Netherlands Embassy during 2011-2013. Dr. Avihingsanon earned scholarships to attend global workshops and conferences, including the European AIDS Conference and International AIDS Society from 2007 to 2022. Early in her career, she was recognized as Best Doctor at Samutsakorn Hospital in 1998 and served as chief resident at King Chulalongkorn Memorial Hospital in 1997.

Research Focus

Dr. Anchalee Avihingsanon is a distinguished researcher specializing in HIV and Hepatitis C co-infections, with a strong focus on antiretroviral therapy optimization, pharmacokinetics, and treatment outcomes. Her work includes evaluating minimal monitoring HCV treatments, assessing drug interactions in people living with HIV, and improving health-related quality of life for patients. She also investigates malnutrition, sarcopenia risks in elderly HIV patients, and liver fibrosis progression using advanced diagnostics. Anchalee’s contributions significantly impact infectious disease management, particularly in Asian populations, aiming to enhance therapy safety, efficacy, and accessibility.

Publication Top Notes

Impact of a minimal monitoring HCV treatment approach on Health-Related Quality of Life
The population pharmacokinetics of dolutegravir co‐administered with rifampicin in Thai people living with HIV: Assessment of alternative dosing regimens
Performance of Elecsys® HCV Duo Immunoassay for Diagnosis and Assessment of Treatment Response in HCV Patients with or without HIV Infection
The Risk of Malnutrition and Sarcopenia in Elderly People Living with HIV during the COVID-19 Pandemic
Pharmacokinetics of Sofosbuvir/Velpatasvir and efficacy of an alternate‐day treatment in hemodialysis patients with chronic hepatitis C infection
Efficacy and safety of switching to bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trials
The 25th Bangkok International Symposium on HIV Medicine
Dose optimization with population pharmacokinetics of ritonavir-boosted lopinavir for Thai people living with HIV with and without active tuberculosis
Conference Proceedings from the Virtual 24th Bangkok International Symposium on HIV Medicine
Third‐line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource‐limited settings: ACTG A5288 strategy trial

Dr.Zhen Cao, Pharmaceutical Policy and Regulation ,Best Researcher Award

Dr.Zhen Cao, Pharmaceutical Policy and Regulation ,Best Researcher Award

Dr.Zhen Cao, at School of Public Health, Capital Medical University,China

Author Profile

Academic and Professional Background 🌟

Cao Zhen is a dedicated doctoral candidate at the School of Public Health, Capital Medical University, specializing in health policy and hospital management. With a robust academic foundation, Cao Zhen is a valued member of the Expert Pool for Project Funding Supervision at the National Health Commission. Her impressive track record includes overseeing two provincial and ministerial-level projects, participation in a National Social Science Foundation project, and contributing to numerous other provincial and ministerial-level initiatives. Her scholarly contributions are evidenced by the publication of nine academic papers in reputable journals.

 


Research and Innovations 🔬📊

  • Completed/Ongoing Research Projects: 15
  • Consultancy/Industry Projects: 2
  • Journals Published (SCI, Scopus, etc.): 9
  • Patents Published/Under Process: 2
  • Collaborations: Notably collaborated with the National Health Commission of the People’s Republic of China during the COVID-19 pandemic to study funding and material support for epidemic prevention and control, as well as the economic operation of hospitals. This collaboration provided crucial decision-making support to tackle pandemic-related challenges.

Professional Memberships 🏅

  • People’s Republic of China Health and Wellness Commission
  • Project Funding Supervision Expert Pool

Research Areas 🔍

  • Hospital Management
  • Health Policy

 

🎓Publication Top Noted:

Paper Title :Adenylyl cyclase localization to the uropod of aggregating Dictyostelium cells requires RacC
    • Authors: Sherly I Celada, Guoliang Li, Lindsay J Celada, Wenfu Lu, Thanigaivelan Kanagasabai, Weiran Feng, Zhen Cao, Nazifa Salsabeel, Ninghui Mao, LaKendria K Brown, Zaniya A Mark, Michael G Izban, Billy R Ballard, Xinchun Zhou, Samuel E Adunyah, Robert J Matusik, Xiaofei Wang, Zhenbang Chen
    • Journal: Molecular Oncology
    • Year:2023
    • Citations : 3

     

Paper Title :Alternative transcription initiation leads to expression of a novel ALK isoform in cancer
  • Authors: Thomas Wiesner, William Lee, Anna C Obenauf, Leili Ran, Rajmohan Murali, Qi Fan Zhang, Elissa WP Wong, Wenhuo Hu, Sasinya N Scott, Ronak H Shah, Iñigo Landa, Julia Button, Nathalie Lailler, Andrea Sboner, Dong Gao, Devan A Murphy, Zhen Cao, Shipra Shukla, Travis J Hollmann, Lu Wang, Laetitia Borsu, Taha Merghoub, Gary K Schwartz, Michael A Postow, Charlotte E Ariyan, James A Fagin, Deyou Zheng, Marc Ladanyi, Klaus J Busam, Michael F Berger, Yu Chen, Ping Chi
  • Journal: Nature
  • Year:2015
  • Citations : 240
Paper Title : Combined inhibition of MAP kinase and KIT signaling synergistically destabilizes ETV1 and suppresses GIST tumor growth
  • Authors: Leili Ran, Inna Sirota, Zhen Cao, Devan Murphy, Yuedan Chen, Shipra Shukla, Yuanyuan Xie, Michael C Kaufmann, Dong Gao, Sinan Zhu, Ferdinando Rossi, John Wongvipat, Takahiro Taguchi, William D Tap, Ingo K Mellinghoff, Peter Besmer, Cristina R Antonescu, Yu Chen, Ping Chi
  • Journal: Cancer discovery
  • Year:2015
  • Citations :130
Paper Title :SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer
  • Authors:Ping Mu, Zeda Zhang, Matteo Benelli, Wouter R Karthaus, Elizabeth Hoover, Chi-Chao Chen, John Wongvipat, Sheng-Yu Ku, Dong Gao, Zhen Cao, Neel Shah, Elizabeth J Adams, Wassim Abida, Philip A Watson, Davide Prandi, Chun-Hao Huang, Elisa De Stanchina, Scott W Lowe, Leigh Ellis, Himisha Beltran, Mark A Rubin, David W Goodrich, Francesca Demichelis, Charles L Sawyers
  • Journal:Science
  • Year: 2017
  • Citations :905
Paper Title : Loss of CHD1 promotes heterogeneous mechanisms of resistance to AR-targeted therapy via chromatin dysregulation
  • Authors: Zeda Zhang, Chuanli Zhou, Xiaoling Li, Spencer D Barnes, Su Deng, Elizabeth Hoover, Chi-Chao Chen, Young Sun Lee, Yanxiao Zhang, Choushi Wang, Lauren A Metang, Chao Wu, Carla Rodriguez Tirado, Nickolas A Johnson, John Wongvipat, Kristina Navrazhina, Zhen Cao, Danielle Choi, Chun-Hao Huang, Eliot Linton, Xiaoping Chen, Yupu Liang, Christopher E Mason, Elisa de Stanchina, Wassim Abida, Amaia Lujambio, Sheng Li, Scott W Lowe, Joshua T Mendell, Venkat S Malladi, Charles L Sawyers, Ping Mu
  • Journal: Cancer cell
  • Year: 2020
  • Citations : 114